In September, Eli Lilly filed lawsuits against eight companies in the U.S. that it claims are producing or selling compounded versions of its blockbuster diabetes drug Mounjaro.
Now, a month later, Lilly is going after 11 online pharmacies—including several overseas—that the company believes are importing, selling or distributing unauthorized versions of the treatment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,